Shandong Camasy Biotechnology Company Limited was founded in 2009 and headquartered in Jinan, Shandong, China, which is an innovative technology company dedicated to R&D, production and sales of innovative drugs, APIs and pharmaceutical intermediates, raw materials of high-end dietary supplements and rehabilitation food.

Camasy strives to provide healthy and safe high-end dietary supplement raw materials, innovative drugs, APIs and pharmaceutical intermediates for global consumers. At present, the company's customers and consumers are located in more than 30 countries and regions around the world.

Camasy can supply a large number of high-end dietary supplements such as PQQ, (S, R)-Equol, Sucrose palmitate and more than 20 kinds of APIs.

Camasy attaches great importance to the research and development work. In addition to the process development of conventional products, we have increased the investment in the research and development of innovative drugs and had completed the molecular screening of new drugs for SGLT-2, PDE-V, EGFR and other targets, among which PDE-V target new drugs have successfully completed the pre-clinical research and will enter the clinical research.